An epidemiologic investigation was done after 3 patients contracted Ochrobactrum anthropi meningitis at one hospital in October 1994. Neurosurgical patients with pericardial tissue implants were at greater risk of infection than other neurosurgical patients (3/14vs. 0/566; P < .001). Cultures of implants removed from 2 case-patients, an implant at implantation, a nonimplanted pericardial tissue, and an unwrapped but unopened bottIe of Hanks' balanced salt solution (HBSS) grew O. anthropi. Patient and tissue isolates had identical genotypes; the isolate from the HBSS bottle had a unique genotype. Culture samples from an unopened HBSS bottle and from pericardial tissue grew Pseudomonas stutzeri of the same genotype; however, no P. stutzeri infections were detected. The investigation documented intrinsic P. stutzeri contamination of HBSS. O. anthropi contamination of tissues occurred during processing, possiblydue to extrinsic contamination of HBSS. Active surveillance is needed to detect infection in patients receiving transplanted tissues, and rigorous infection control practices are necessary during tissue harvesting and processing to ensure sterility.
Transplantation of tissues of both human (allograft) and animal (xenograft) origin is increasing. Tissue grafts often require extensive processing after harvest and preservation before implantation. Infectious complications associated with tissue grafts include rabies from corneal transplants and CreutzfeldtJakob disease from cadaveric dural tissue [1, 2] . Infectioncontrol guidelines for obtaining and processing tissues for transplantation have not been published; nevertheless, these procedures require strict adherence to aseptic technique to avoid contamination of the transplanted tissue.
Ochrobactrum anthropi (formerly Centers for Disease Control and Prevention [CDC] group Vd, Achromobacter species) is a motile gram-negative bacillus recently reported to cause nosocomial infections [3, 4] . When 3 pediatric neurosurgical patients contracted 0. anthropi meningitis at Primary Children's Medical Center (PCMC), a 232-bed pediatric teaching hospital, an investigation was initiated; no prior 0. anthropi infections had occurred at this institution. All 3 patients had undergone neurosurgical procedures in which cadaveric pericardium, prepared at an adjacent hospital, University of Utah Hospital (UUH), had been used as a dural graft. A preliminary investigation by PCMC and UUH personnel suggested that the pericardial tissue grafts may have been contaminated during processing. Hanks' balanced salt solution (HBSS) from the same lot (l7N2041; Life Technologies, Grand Island, NY) was used to prepare the tissues associated with infection.
Before April 1994, dural defects created during neurosurgical procedures done at PCMC were closed with autologous fascia or cadaveric dural tissue. Because of concerns about transmission of infectious agents and decreased availability of tissue, use of dural tissue was discontinued. In December 1993, the first pericardial tissue was harvested at UUH, and the first pericardial implant was done at PCMC in April 1994.
Methods
Definition and identification of case-patients. A case-patient was defined as any PCMC neurosurgery patient who received a pericardial tissue graft between 27 April and 16 November 1994 (the study period) and subsequently contracted 0. anthropi meningitis. To identify case-patients, we reviewed PCMC and UUH microbiology records for all O. anthropi and unusual gram-negative bacteria isolates and PCMC infection-control and surgery records for all neurosurgical graft recipients.
Procedural review. We reviewed all PCMC neurosurgery procedures and operative reports involving pericardial transplants during the study period, interviewed neurosurgeons and other operating room (OR) staff, and observed a neurosurgical procedure. We reviewed UUH tissue bank policies and procedures, examined records for all pericardial tissue harvest and processing procedures, observed these procedures, and interviewed staff.
Epidemiologic studies. To identify patients at greatest risk of infection, we compared the rate of O. anthropi infection in neuro-surgery patients who had had a pericardial tissue graft with the rate in those who had not. To assess risk factors for 0. anthropi infection, we conducted a cohort study of all patients receiving pericardial tissue grafts during the study period. The medical records of these patients were reviewed for cadaveric tissue harvest and processing data, patient demographics, clinical signs and symptoms of infection, and pre-, intra-, and postoperative data.
Laboratory review and studies. Next, we reviewed laboratory records for 0. anthropi and 0. anthropi-Iike organisms. Culture samples were obtained from frozen pericardial tissues; processing solutions, operating rooms, tissue bank harvest and preparation areas and water sources in these areas; microbiology work surfaces; and the hands of tissue bank and microbiology personnel.
Environmental sampling was done using sterile swabs and 3 mL of sterile phosphate buffer (Future Medical Technologies International, Decatur, GA). Swab specimens were processed using the swab-rinse sampling method [5] and assayed using the membranefiltration technique [6] .
Culture samples from hands were obtained using wipe-rinse and membrane-filtration techniques [7] . HBSS was cultured by pouring the HBSS from previously opened and unopened bottles through a OA5-llm membrane filter. Duplicate sets of filter membranes from swab-rinse samples and HBSS were inoculated onto trypticase soy agar; membranes from water samples were inoculated onto R 2A (Becton Dickinson, Cockeysville, MD); cultures were incubated at 25°C and 35°C for 7 days. Membranes from wipe samples were placed on Columbia nutrient agar and MacConkey's agar plates and incubated at 35°C for 48 h.
Pericardial tissue samples (l g) were aseptically homogenized in 10 mL of sterile saline. A O.I-mL aliquot of the homogenate was used to inoculate chocolate (C0 2 ) , blood (aerobic and anaerobic), MacConkey's agar, or thioglycollate broth (or all four) and incubated for 14 days at 35°C. Endotoxin was assayed using a turbidimetric Iimulus amebocyte lysate assay (LAL-5000 version 2; Associates of Cape Cod, Woods Hole, MA). 0. anthropi was identified at CDC using both conventional methods [8] and the Biolog MicroStation system (Biolog, Haywood, CA). All 0. anthropi and P. stutzeri isolates were typed by pulsed-field gel electrophoresis (PFGE). Genomic DNA was digested with restriction endonuclease Spel, and PFGE was done with a contour-clamped homogeneous electric field-DRll apparatus at 14°C for 24 h at 200 V [9] .
Statistical methods. Data were collected on standardized forms, entered into a computer data base, and analyzed using Epi Info version 6 [10] . Categorical variables were compared by Fisher's exact or X 2 test. Continuous variables were compared using the Wilcoxon rank sum test.
Results
Three patients met the case definition. Case-patients had a median age of 6.5 years (range, 3.5-9); all were male and white. The indications for neurosurgery included shunt revision (l case-patient) and medulloblastoma removal (2 case-patients); all 3 received prophylaxis with nafcillin before surgery. The median time from surgery until the first positive culture for 0. anthropi was 21 days (range, 14-60). However, 2 casepatients had insidious onset of infection with fevers but no clear source of infection. All patient 0. anthropi isolates were susceptible only to imipenemlcilastatin, gentamicin, tetracycline, and ciprofloxacin. All case-patient blood cultures were negative for the organism.
Two of 3 case-patients had pleocytosis (median, 8 white blood cells/mrrr'; range, 1-89). All 3 had positive CSF cultures for 0. anthropi. CSF levels of protein (median, 32 gil; range, 25-76) and glucose (median, 38 mmol/L; range, 35-64) varied. All case-patients were treated with imipenemlcilastatin and gentamicin for a median of 6 weeks, and the surgical grafts were removed; all case-patients survived.
Of 580 patients undergoing neurosurgery procedures during the study period, those receiving pericardial tissue grafts were significantly more likely than those not receiving grafts to develop an 0. anthropi infection (3/14 vs. 0/566; P < .001).
When we compared risk factors for developing 0. anthropi infections among graft recipients, case-and noncase-patients were similar in age, sex, race, and other demographic characteristics. In contrast, case-patients were more likely than noncasepatients to be immunosuppressed patient received two grafts in two separate operations) or to have had a drain placed during the neurosurgery procedure (2/ 3 vs. 1/11; P == .04). A protocol existed for harvesting and processing of tissues (figure 1). Tissues were aseptically harvested at the medical examiner's office. A small piece of harvested tissue was sent for culture, and the remaining pericardial tissue was stored in a sterile container with RPMI and placed on ice.
Tissue was transported to the UUH tissue bank the day of harvest, where it was stored in the refrigerator (2-6°C) until processing and cryofreezing. After processing, the tissue was placed in a sterile plastic bag with 10 mL of the cryopreservative. The plastic bag was vacuum-sealed, placed in a sterile foil bag, sealed, and placed in the cryofreezer (-70°C) until use.
Fluids used in pericardial tissue processing were HBSS, dimethyl sulfoxide (DMSO), albumin, RPMI, gentamicin, penicillin, and normal saline; according to the commercial sources, all were sterile. HBSS and RPMI are marketed for in vitro tissue culture use only. The other processing fluids are marketed for in vivo use; DMSO has no specified usage on the bottle, but the supplier states it is used for cryopreservation of platelets and bone marrow. During the study period, one or more lots of HBSS (two), DMSO (two), albumin (two), RPMI (five), gentamicin (one), or penicillin (two) were used in pericardium processing.
All neurosurgery procedures were done by the same surgical team in one OR. Pericardial tissue for implant was not brought to the OR from the tissue bank until needed for implant. Before use, the tissue was warmed in sterile normal saline and a sample was removed for culture, then the remaining tissue was implanted.
Observations and interviews indicated that harvest and processing procedures were followed generally but that cultures were not all obtained at protocol-indicated intervals. Tissue processing was generally done aseptically, but we observed several breaks in sterile technique during one procedure (i.e., bare hands were used to place the sterile drape on the processing table and the drape was contacted by nonsterile clothing).
During the study period, pericardial tissues from 28 cadaveric donors were harvested and processed into 40 separate pieces of pericardial tissue. Three pieces of pericardial tissue were harvested for research purposes only; II pieces had been discarded (1 was too old for implantation, 4 grew various non-0. anthropi bacteria, 3 were not cultured, and 3 were discarded without a given reason). Fourteen pieces had been implanted into 13 recipients. When the outbreak was recognized, the implantation of pericardial tissue was terminated; II of 12 remaining pericardial tissues were cultured. These II pieces of fully processed, nonimplanted pericardial tissue were culturepositive for a variety of gram-negative organisms, including Pseudomonas stutzeri but not 0. anthropi; these tissues had never been in PCMC.
Of the pericardial tissue recipients, 3 developed infections (case-patients); their implants were removed after antimicrobial therapy was begun. Cultures of two removed implants grew 0. anthropi (table 1) , and the third was sterile. Cultures of samples from one implant (processed at UUH but implanted at a third hospital) obtained at implantation into a patient who remained asymptomatic, from one pericardial tissue that had not been implanted, and from one unwrapped, unopened HBSS bottle from the UUH tissue bank grew 0. anthropi; all cultures were done at UUH, and none had ever been inside PCMC. All 0. anthropi isolates were confirmed at CDC. All 0. anthropi isolates from case-patients and tissues were the same genotype; in contrast, the 0. anthropi isolate from the open bottle of HBSS was unique (table I, figure 2) . A culture sample from a wrapped unopened bottle of HBSS from the tissue bank grew P. stutzeri. The P. stutzeri isolates from both the HBSS and the pericardial tissue had identical genotypes (genotype a). No pericardial tissue recipient contracted a P. stutzeri infection. All other culture samples from tissue, solutions, the OR, the harvest and processing areas and water, the microbiology laboratory areas, and personnel hands were negative for 0. anthropi and P. stutzeri.
Only two lots of HBSS (17N2041 and 22K0532) were used to process pericardial tissue. Lot 22K0532 was used to process only 2 pieces of pericardium; cultures of these tissues were sterile, and neither recipient developed meningitis. For both of these pieces, separate lots of DMSO and albumin were used; none of these lots was used to process any other pericardial tissue. The RPMI, gentamicin, and penicillin used to process these 2 pieces of pericardium also were used to process many other pieces of tissue. Cultures of all other processing solutions were negative for 0. anthropi and P. stutzeri. All positive cultures of HBSS were from lot I7N204I; bottles of this lot also were positive for endotoxin.
Discussion

0.
anthropi is a gram-negative bacillus normally found in the environment [II] . It has rarely been reported as a human pathogen [3, 4, 12, 13] .
We documented a cluster of nosocomial meningitis cases caused by O. anthropi transmitted by contaminated human pericardial tissue grafts. The source of contamination was demonstrated by the epidemiologic association with graft implantation, the presence of 0. anthropi in 2 explanted specimens, and the presence of the organism in 2 other grafts not associated with clinical disease, I of which was fully processed but never used. Extrinsic contamination during harvesting was unlikely, since all postprocurement and preprocessing cultures were sterile. HBSS bottles were positive for endotoxin and for 0. anthropi. The investigation suggests probable 0. anthropi contamination of the pericardial grafts during processing or freezing. The breaches in sterile technique and the presence of O. anthropi in an unwrapped, unopened HBSS bottle are consistent with this explanation. A pseudoepidemic due to contamination of the tissue in one of the microbiology laboratories was ruled out, since both PCMC and UUH laboratories isolated the 0. anthropi separately from different specimens, and there were no other isolates of O. anthropi from patients at these hospitals.
We were unable to identify the exact source of 0. anthropi. All positive pericardial tissue cultures occurred in tissues harvested and processed from 13 August to 22 September. Our culture samples from the environment and personnel were not obtained until nearly 3 months after the last 0. anthropi-positive tissue was processed; none was positive for 0. anthropi. Thus, it is likely that the source was no longer present by the time of our investigation.
After the manufacturer and the Food and Drug Administration were alerted to the contaminated bottles of HBSS, the company issued a voluntary recall of lot number 17N2041.
As tissue transplant technology continues to grow, infection control problems, including infection with unusual human pathogens, may become increasingly common. Issues, such as tissue preparation with solutions marketed for in vitro use only, need to be addressed in the tissue banking industry. Furthermore, routine infection-control practices, such as cultures to check sterility of transplant tissue before and after processing and storage and posttransplant surveillance, are critical. As tissue transplantation increases, more stringent infection-control guidelines will be needed.
